INDSWIFT LABORATORIES
Back to Cashflow Statement
|
INDSWIFT LABORATORIES Last 5 Year Cash Flow from Financing Activities History
[Consolidated]
Mar2024 | Mar2023 | Mar2022 | Mar2021 | Mar2020 | |
---|---|---|---|---|---|
Cash Flow from Financing Activities | ₹681 Cr | ₹-186 Cr | ₹-141 Cr | ₹-124 Cr | ₹-133 Cr |
What is the latest Cash Flow from Financing Activities ratio of INDSWIFT LABORATORIES ?
Year | Cash Flow from Financing Activities |
---|---|
Mar2024 | ₹681 Cr |
Mar2023 | ₹-186 Cr |
Mar2022 | ₹-141 Cr |
Mar2021 | ₹-124 Cr |
Mar2020 | ₹-133 Cr |
How is Cash Flow from Financing Activities of INDSWIFT LABORATORIES Trending?
Years | Cash Flow from Financing Activities | % Change | |
---|---|---|---|
Mar2024 | ₹681 Cr | Positive | |
Mar2023 | ₹-186 Cr | Negative | |
Mar2022 | ₹-141 Cr | Negative | |
Mar2021 | ₹-124 Cr | Negative | |
Mar2020 | ₹-133 Cr | - |
Compare Cash Flow from Financing Activities of peers of INDSWIFT LABORATORIES
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
INDSWIFT LABORATORIES | ₹521.3 Cr | 4.1% | -3.1% | -34.3% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹406,123.0 Cr | 0.2% | 1% | 6.3% | Stock Analytics | |
DIVIS LABORATORIES | ₹152,844.0 Cr | 6.8% | 1.6% | 53.3% | Stock Analytics | |
CIPLA | ₹120,860.0 Cr | 4.4% | 2.9% | 4.1% | Stock Analytics | |
TORRENT PHARMACEUTICALS | ₹109,020.0 Cr | -0.7% | 4% | 25.1% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹96,755.1 Cr | 4.6% | 4.9% | -6.2% | Stock Analytics |
INDSWIFT LABORATORIES Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
INDSWIFT LABORATORIES | 4.1% |
-3.1% |
-34.3% |
SENSEX | 5.3% |
4% |
3.2% |
You may also like the below Video Courses